An Open-label, Baseline-controlled, Multicenter, Phase 3 Dose-titration Study to Evaluate Efficacy, Safety and Pharmacokinetics of Mirabegron in Children and Adolescents from 3 to less than 18 Years of Age
Clinical Trial Grant
Administered By
Urology
Awarded By
Astellas Pharma Inc.
Start Date
June 6, 2018
End Date
June 30, 2020
Administered By
Urology
Awarded By
Astellas Pharma Inc.
Start Date
June 6, 2018
End Date
June 30, 2020